- Home
- PFN vs AGL Comparison
PFN vs AGL Comparison
Compare PFN & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFN
- AGL
- Stock Information
- Founded
- PFN 2004
- AGL 2016
- Country
- PFN United States
- AGL United States
- Employees
- PFN N/A
- AGL N/A
- Industry
- PFN Finance/Investors Services
- AGL Managed Health Care
- Sector
- PFN Finance
- AGL Health Care
- Exchange
- PFN Nasdaq
- AGL Nasdaq
- Market Cap
- PFN 661.3M
- AGL 655.1M
- IPO Year
- PFN N/A
- AGL 2021
- Fundamental
- Price
- PFN $7.48
- AGL $1.89
- Analyst Decision
- PFN
- AGL Hold
- Analyst Count
- PFN 0
- AGL 17
- Target Price
- PFN N/A
- AGL $4.63
- AVG Volume (30 Days)
- PFN 331.7K
- AGL 5.0M
- Earning Date
- PFN 01-01-0001
- AGL 11-07-2024
- Dividend Yield
- PFN 11.66%
- AGL N/A
- EPS Growth
- PFN N/A
- AGL N/A
- EPS
- PFN N/A
- AGL N/A
- Revenue
- PFN N/A
- AGL $5,594,117,000.00
- Revenue This Year
- PFN N/A
- AGL $41.07
- Revenue Next Year
- PFN N/A
- AGL $22.27
- P/E Ratio
- PFN N/A
- AGL N/A
- Revenue Growth
- PFN N/A
- AGL 54.10
- 52 Week Low
- PFN $5.94
- AGL $1.50
- 52 Week High
- PFN $7.58
- AGL $13.76
- Technical
- Relative Strength Index (RSI)
- PFN 46.04
- AGL 38.98
- Support Level
- PFN $7.32
- AGL $1.50
- Resistance Level
- PFN $7.49
- AGL $2.20
- Average True Range (ATR)
- PFN 0.06
- AGL 0.20
- MACD
- PFN -0.00
- AGL 0.00
- Stochastic Oscillator
- PFN 55.36
- AGL 23.49
About PFN PIMCO Income Strategy Fund II
PIMCO Income Strategy Fund II is a closed-ended fixed income mutual fund. The company's primary investment objective is to seek high current income, consistent with the preservation of capital. The fund invests in a range of securities, such as corporate bonds and notes, non-agency mortgage-backed securities, asset-backed securities, municipal bonds and notes, short-term instruments, sovereign Issues, preferred Securities and others.
About AGL agilon health inc.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.